PURCHASE, N.Y., Oct. 31 /PRNewswire-FirstCall/ -- Nutrition 21, Inc. (Nasdaq: NXXI - News), a developer and marketer of nutritional supplements that help consumers manage blood sugar levels, improve cardiovascular health, enhance memory and address chronic joint pain, will report preliminary financial results -- prior to the opening of the market -- on Thursday, November 13, 2008 for the first quarter of fiscal year 2009, ended September 30, 2008. The Company has scheduled a conference call to review the results later that morning, Thursday, November 13, 2008 at 10:00AM ET.
 
Participants can dial (866) 562-9910 or (706) 679-5064 to access the conference call, or can listen via a live Internet web cast, which can be found at http://www.nutrition21.com. A replay of the call will be available by visiting http://www.nutrition21.com for 30 days or by calling (800) 642-1687 or (706) 645-9291, access code 69805873, through November 16, 2008.

About Nutrition 21

Nutrition 21, Inc., headquartered in Purchase, NY, is a nutritional bioscience company and the maker of chromium picolinate-based and omega-3 fish oil-based supplements with health benefits substantiated by clinical research. Nutrition 21 holds more than 30 patents for nutrition products and uses. Nutrition 21's portfolio of health and wellness brands include: Chromax®, Iceland Health Advanced Memory Formula(TM), Diabetes Essentials®, Iceland Health® Maximum Strength Omega-3 and Iceland Health® Joint Relief. The company also manufactures private label supplements and ingredients for third parties. Nutrition 21 products are sold nationally through more than 29,000 major food, drug and super center stores as well as internationally. For more information please visit http://www.nutrition21.com.

     Contacts:
     Nutrition 21, Inc.             Lytham Partners, LLC
     Alan Kirschbaum                Joe Diaz, Robert Blum, Joe Dorame
     914-701-4500                   (602) 889-9700